Scientific Programme
|
|
|
- Gyles Hampton
- 5 years ago
- Views:
Transcription
1 11th National Conference of AIDS Society of India- ASICON 2018 Hotel ITC Gardenia, Bangalore : Nov 2-4, 2018 Academic Partners ASHA Foundation, Bangalore; CAPRISA-South Africa; Forum of Parliamentarians on AIDS; Gilead Sciences Inc.; Medical Council of India (MCI)*; National AIDS Control Organisation (NACO); Peoples Health Organisation-India (PHO); UNAIDS Breaking Barriers for Health, Hope and Healing Day 1: Nov 2, 2018: 09 09:00-09:20 Welcome Remarks and Scientific Programme Outline Scientific Programme Scientific Dr. Jyoti Dhar, UK Dr. N Kumarasamy, Chennai 09:20-10:05 Oral Abstract Session I (1-4) Dr. Jyoti Dhar, UK Dr. Shirley James, Bangalore Session I 10:05-11:05 1. Elevated Alkaline Phosphatase in Patients with HIV: A spark in the dark? 2. Study of Sero-Positivity Of HBsAg & Anti-HCV Antibody In HIV Positive Individuals 3. Leveraging surveillance and community-driven case detection methods among the Key Population 4. India moving online: Its implications to HIV intervention program for Key Population HIV Epidemic Dr. Avik Medda, Kolkata Dr. K.K.Sharathchandra, Kalaburagi Dr. M.R.Parthasarathy, New Delhi Dr. P. Shah, New Delhi Dr. Herve Fleury, France Dr. Naval Chandra, Hyderabad 10:05-10:20 Global Epidemiology of HIV Dr. Mukta Sharma, WHO 10:20-10:40 NACO response to Indian HIV epidemic Dr. R S Gupta, NACO 10:40-10:55 Success and Challenges from Private sector Dr. Ishwar Gilada, Mumbai 11:05-11:20 Tea Break Session II 11:20-12:10 Diagnosis and Monitoring Dr. David Katzenstein, USA, Dr.V Chandrasekhar,Warangal 11:20-11:40 Implications of new international monitoring Dr. Vanita Gupta, Chandigarh SACS guidelines on National Program 11:40-12:00 Point of care assays for HIV: Where do we stand? Dr. Preeti Mehta, Mumbai
2 12:10-13:00 Inaugural ceremony & Felicitations Life-time Achievement Awards: Dr. Narendra Singh Potsangbam, Imphal Dr S Sacchidanand, Vice-Chancellor, Rajiv Gandhi University of Health Sciences & Director of Medical Education, Govt. of Karnataka 13:00-14:00 Lunch 14:00-14:35 Oral Abstracts Session- II (5-7) Dr. N Kumarasamy, Chennai Dr. K Gopalakrishnan, Calicut 5. Pitfalls in the Roadmap to Elimination of Mother To Child Transmission (EMTCT) of HIV in India 6. New solutions and old problems: Test and Treat Policy in South Gujarat 7. Enhanced Adherence Counseling in Mumbai ART: Scale up of a pilot project from an ART center Dr. U.C.Samudyatha, Surat Dr. Manvendra Singh Rathore, Surat Dr. Shrikala Acharya, Mumbai Session III 14:35-15:00 Plenary 1: Dr. Suniti Solomon Oration Newer approaches for HIV Prevention Dr. Sunil Solomon, Chennai Dr. G D Ravindran, Bangalore Dr. Nirupama Sista, USA Session IV 15:00-16: : Challenges in the first 90 Dr. George Oommen, Mumbai Dr. S Murugan, Tirunelveli 15:00-15:20 Test and Treat: Where are we with testing? Dr. R.S.Gupta, NACO 15:20-15:40 Testing strategies in hidden and key populations Dr. Sunil Solomon, Chennai 15:40-16:00 Challenges in linkage to care Dr. B B Rewari, WHO 16:15-16:30 Tea Break Session V 16:30-17:05 Debate: How to identify people living with HIV- Should we test all citizens? How often? For Dr. Harsh Toshniwal, Ahmedabad Dr. VHT Swamy, Mysore Moderators: Dr. B.B.Rewari, WHO Dr. Alex Thomas, Bangalore Against Dr. Prakash Bora, Mumbai Dr. Ketan Ranpariya, Surat Session VI 17:05-18:15 Prevention Strategies -An Update Dr. Glory Alexander, Bangalore Dr. Satish Rao, Mangalore :25 Emerging Sexually Transmitted Infections (STIs) Dr. Jyoti Dhar, UK 17:25-17:45 PrEP Demonstration Programmes in India Dr. Nomita Chandhiok, ICMR 17:45-18:05 Preventing stigma: Role of Law Dr. B C Gupta, New Delhi 19:00-20:00: ASI Annual General Body Meeting
3 Day 2: Nov 3, 2018: 09:00-09:40 Oral Abstract Presentations III (8-10) Dr. Basavaraj Sajjan, Hubli Session VII 09:40-11:15 8. Vitality of Antiretroviral Compliance: Cryptococcal Meningitis Survival Analysis 9. Level of Awareness about Universal Precautions and PEP for HIV among Interns HIV and Co-infections Dr. S.D. Tilekar, Panchgani Dr. Prashant Mathapati, Salem Dr. P Narendra Singh, Imphal 09:40-10:00 Update on HPV management Dr. Joel Palefsky, USA 10:00-10:20 What is new in HCV? Dr. Juergen Rockstroh, Germany 10:20-10:40 Update on HBV therapy Dr. Ed Wilkins/Dr.Jyoti Dhar, UK 10:40-11:00 What is new in POC for co-infections? Dr. David Katzenstein,USA 11:15-11:30 Tea Break Session VIII 11:30-13:00 State of ART Dr. Franco Buonaguro, Italy, Dr. Ramesh Bhat,IADVL,Mangalore 11:30-11:50 What is new in initiating ART? 11:50-12:10 Pattern of resistance to PIs and Integrase inhibitors Dr. Rami Kantor, USA 12:10-12:30 Current 2 nd Line and 3 rd Line ART regimens Dr. N Kumarasamy, Chennai 12:30-12:50 Cure of HIV Dr. Herve Fleury, France 13:00-14:00 Lunch Session IX 14:00-15:30 Session X 15:30-16:00 Interactive clinical case discussions Case Presentations Dr. Hiten Thaker, UK (Patient readiness) Dr. S K Guha, Kolkata (Resistance) Dr. R Sajithkumar, Kottayam(Toxicities) Dr. G Manoharan, Coimbatore(Mitochondrial Myopathy) Dr. Raj Harjani, Mumbai (Malignancy) Dr. Rajeev Mehta, Mumbai (Radiology) Plenary 2: Dr. Mark Wainberg Oration Newer targets & ARVs in pipeline Panelists: Dr. Nalin Nag, Delhi Dr. Murugesh Pastapur, Gulbarga Dr. Salil Bendre, Mumbai Dr. Ishwar Gilada, Mumbai Dr. Juergen Rockstroh, Germany 16:00-16:15 Tea-Break
4 Session XI 16:15-17:30 ARVs for special populations Dr. Ruby Bansal, Ghaziabad ARVs for maintenance and long acting ARVs 16:35-16:50 ART in Children and Adolescent Dr. S N Mothi, Mysore 16:50-17:05 What is new in ART for Women? Dr. S. Poongulali, Chennai 17:05-17:20 HIV and Aging Dr. P Narendra Singh, Imphal Session XII 17:30-19:00 ARV toxicities Dr. Rami Kantor, USA Dr. Sumantoke Bagchi, Mumbai 17:30-17:50 Renal toxicities - Do we need TAF in India? Dr. Atul Patel, Ahmedabad 17:50-18:05 Chaos with EFV- Is there a role for Rilpivirine? 18:05-18:25 Long-term PI toxicities- What to do? Dr. Sanjay Pujari, Pune 18:25-18:45 Common drug interactions with ARVs Dr. Hiten Thaker, UK
5 Day 3: Nov 4, 2018: Session XIII 08:30-10:00 HIV and Non-communicable diseases Dr. Ravi Shankar, Bangalore Dr. M Satyanarayanan, Hyderabad 08:30-08:45 HIV and Cardiac Dr. Alok Shetty, Bangalore 08:45-09:00 HIV and kidney Dr. Priyanka P, Bangalore 09:00-09:15 HIV & Neurocognitive disorders Dr. Ameet Dravid, Pune 09:15-09:30 HIV & Metabolic complications Dr. Trupti Gilada, Mumbai 09:30-09:50 HIV and non AIDS Malignancies Dr. Franco Buonaguro, Italy Session XIV 10:00-10:25 Plenary III: Dr. K C Mohanty Oration TB HIV Integration: Overview Dr. G D Ravindran, Bangalore Dr. Kogie Naidoo, South Africa 10:25-10:40 Tea Break Session XV 10:40-11:45 TB-HIV Co-enemies Dr. Srikanth Tripathy, Chennai Dr. Milind Bhrushundi, Nagpur 10:40-11:00 TBD TBD 11:00-11:15 Epidemiology of MDR TB in India Dr. Sanjay Kumar Matto, RNTCP 11:15-11:30 Newer drugs for Treatment and Prevention Dr. K Satish, Bangalore Session XVI 11: Emerging issues in HIV in India Dr. Shashi Sangle, Pune 11:45-12:00 Sustainability of Public ARV program in India Dr. R R Gangakedhkar, Pune 12:00-12:15 How to motivate the young doctors into HIV care? Dr. Jyoti Dhar, UK 12:15-12:30 Public-Private Partnership: What can NACO/ASI Do? Dr. Glory Alexander, Bangalore 12:30-12:45 NACO and RNTCP Perspective on PPP NACO/ RNTCP 13:00-13:45 Valedictory function 13:45 onwards Lunch
08:45-08:55 Welcome Remarks and Programme Outline Scientific Co-Chairs
10 th National Conference of AIDS Society of India- ASICON 2017 Academic Partners Association of Physicians in India (API); CAPRISA, South Africa; Forum of Parliamentarians on AIDS; Indian Council of Medical
AIDS SOCIETY OF INDIA th th
www.asi-asicon.org www.asi-asicon.com 9 NATIONAL CONFERENCE OF AIDS SOCIETY OF INDIA 7-9 October 2016 Hotel Sahara Star, Mumbai Eliminating HIV: Progress & Reality Announcement Brochure Welcome Message
versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects
PRE-CONFERENCE WORKSHOPS WEDNESDAY, 24 OCTOBER 2018 10h00 14h00 Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop Pre-Conference Workshop ITREMA trial feedback PrEP for the private
ViiV Healthcare s Position on Prevention in HIV
ViiV Healthcare s Position on Prevention in HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status quo and find new ways of navigating the challenges
Facing the Reality of Multidrug-Resistant Tuberculosis: Challenges and Potential Solutions in India
Board on Health Sciences Policy Forum on Drug Discovery, Development, and Translation Facing the Reality of Multidrug-Resistant Tuberculosis: Challenges and Potential Solutions in India AGENDA Monday and
Program to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
Treat All : From Policy to Action - What will it take?
Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions
A PROFILE OF PATIENTS REGISTERED AT ART CENTRE AT SURAT MUNICIPAL INSTITUTE OF MEDICAL EDUCATION & RESEARCH IN SURAT CITY, GUJARAT, INDIA
A PROFILE OF PATIENTS REGISTERED AT ART CENTRE AT SURAT MUNICIPAL INSTITUTE OF MEDICAL EDUCATION & RESEARCH IN SURAT CITY, GUJARAT, INDIA Modi B, Patel P, Patel S Department of Community Medicine, Surat
CMC VELLORE ANNUAL RHEUMATOLOGY UPDATE Organized by: Department of Clinical Immunology and Rheumatology. 12 May 2017
CMC VELLORE ANNUAL RHEUMATOLOGY UPDATE 2017 Organized by: Department of Clinical Immunology and Rheumatology 12 May 2017 Venue: CK Job Hall, Paul Brand Building, Christian Medical College, Vellore 10.00
( ISNR 2009) PROGRAMME. ( Incorporating Ramachandra Advanced Interventional Neuroradiology (RAIN- 2009)
12 th Annual Conference of Indian Society of Neuro Radiology ( ISNR 2009) PROGRAMME 12 NOVEMBER 2009 : Neuro Intervention Workshop ( Incorporating Ramachandra Advanced Interventional Neuroradiology (RAIN-
HIV Epidemic in India
HIV Epidemic in India Dr.R.R.Gangakhedkar Head, Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research New Delhi Waves in Spread of HIV Epidemic Core Group Bridge Populationmostly
Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART
Thailand s Annual International Training Course (AITC) 2017 Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART I. Proposal Title: Management of Antiretroviral Treatment (ART) and
Session 1B - Auditorium Adult cases - Adherence - Mental health - STIs - Opportunistic Infections - TB - Drug Interactions Panel discussion
CONFERENCE PROGRAMME WEDNESDAY, 24 OCTOBER 2018 08h00 18h00 Registration OFFICIAL MEETING COMMENCES 14h00 15h30 Session 1A Adolescent cases - Teen pregnancy and breast feeding - Previously on PrEP, now
World Health Organization. A Sustainable Health Sector
World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL
rd th 3-4 December 2016, ITC Grand Chola, Chennai, India SCIENTIFIC PROGRAM
8 India Probiotic Symposium th 8 India Probiotic Symposium rd th 3-4 December 2016, ITC Grand Chola, Chennai, India Probiotics in Health - Emerging Opportunities SCIENTIFIC PROGRAM PROGRAM th 8 INDIA PROBIOTIC
PROJECT ŚVETANA (Dawn) Elimination of new HIV infections among children by Scaling up PPTCT services in private health sector
PROJECT ŚVETANA (Dawn) Elimination of new HIV infections among children by Scaling up PPTCT services in private health sector Supported by Global Fund for AIDS, TB and Malaria (GFATM) Oct 2015 Dec 2017
Introduction: WHO recommends that criteria for starting ART be defined in national protocols and that these
ISSN: 0975-766X Available Online through Research Article www.ijptonline.com HEALTH PROFILE OF HIV POSITIVE INDIVIDUALS AT ANTI RETROVIRAL TREATMENT CENTRE, KADAPA DISTRICT Dr.K.Chandra Sekhar *, Dr. K.J.Kishore
Integration of services for HIV/AIDS and sexual and reproductive health
January 2012 Integration of services for HIV/AIDS and sexual and reproductive health Pilot projects in India have paved the way for wider use of effective models, strategies, and tools A9, Qutab Institutional
Tuberculosis-HIV epidemic situation and emerging challenges in North India
NTI Bulletin 2015,51 /1&4, 1 7 Tuberculosis-HIV epidemic situation and emerging challenges in North India Rajesh Deshmukh 1,3, Raghu Ram Rao 2, Shah A 2,3, Sreenivas A Nair 3, R S Gupta 1, SD Khaparde
73rd NATCON Scientific Programme Day-1 (January 05,2019) Registration (08.00AM AM)
73rd NATCON Scientific Programme Day-1 (January 05,2019) Registration (08.00AM-09.00 AM) Time Hall A Hall B Meetings 09.00-09.40 Chair: Dr. V.K. Arora, Dr. L.S. Chauhan, Dr. Radha Munje Oration1: 09.40-10.20
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
ViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV
ViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV ViiV Healthcare is a company 100% committed to HIV, and we are always looking to move beyond the status
INCOFYRA 2018: Integrative Oncology: Future of Cancer Care Scientific Program: January 6, 2018, Saturday, Forenoon
INCOFYRA 2018: Integrative Oncology: Future of Cancer Care Scientific : January 6, 2018, Saturday, Forenoon 9-10:30 am Plenary session 1 Chairperson Dr K S Gopinath, Chairman, HCG, Bengaluru Dr H R Nagendra,
Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV.
Delivering Integrated HIV/TB Services in India: Challenges and Opportunities in National AIDS Control Program (NACP) IV. Introduction: Deshmukh Rajesh 1 Ashok Kumar 1 K.S.Sachdeva 2 Amar Shah 2 India is
Lessons learned and emerging challenges in Global Oral Health
6 th to 9 th November 2014 The Mouth and AIDS: Lessons learned and emerging challenges in Global Oral Health www.ww7india.com Thursday 6 th November PLENARY SESSION 1 Chairs: Deborah Greenspan, Stephen
3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019
3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 Cristiana Oprea MD, Ph.D Associate Professor Carol Davila University of Medicine and Pharmacy Victor Babes Clinical Hospital for Infectious
HIV Situation in South-East Asia. HIV unit Department of Communicable Diseases
HIV Situation in South-East Asia HIV unit Department of Communicable Diseases Outline Magnitude of HIV burden in South-East Asia Progress towards MDGs Regional success stories Issues and concerns Summary
Prevention of Mother to Child Transmission of HIV: Our Experience in South India
pg 62-66 Original Article Prevention of Mother to Child Transmission of HIV: Our Experience in South India Karthekeyani Vijaya 1, Alexander Glory 2, Solomon Eileen 3, Rao Sarita 4, Rao P.S.S.Sunder 5 1
South Africa s National HIV Programme. Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH. 23 October 2018
South Africa s National HIV Programme Dr Zuki Pinini HIV and AIDS and STIs Cluster NDOH 23 October 2018 Overview The HIV and AIDS sub-programme at NDOH is responsible for: policy formulation, coordination,
Overview of the TB epidemic globally and in India
Overview of the TB epidemic globally and in India Dr Soumya Swaminathan Deputy Director General for Programmes 5 th GLOBAL FORUM ON TB VACCINES PARTNERING FOR PROGRESS AND INNOVATION February 20, 2018
SEHAT-The Health Initiative
SEHAT-The Health Initiative Supported by: INDIA VISION FOUNDATION Presented by C. R. Garg Amrita Bahl Background HIV in India 1,065,070,607: Population of India (July 2004 est.) 5.1 million: Estimated
Role of RNTCP in the management MDR-TB
Kamdar DJ, Shah NA, Patel DJ, Parmarr H. Role of RNTCP in the management of MDR-TB. IAIM, 2015; 2(7): 1-5. Original Research Article Role of RNTCP in the management of MDR-TB Deepali J Kamdar 1, Neha A
ANNUAL MEETING OF INDIAN SOCIETY OF NEPHROLOGY SOUTHERN CHAPTER CONFERENCE CALICUT. Date: to Scientific Programme
ANNUAL MEETING OF INDIAN SOCIETY OF NEPHROLOGY SOUTHERN CHAPTER CONFERENCE CALICUT Date: 13.02.2015 to 15.02.2015 Scientific Programme Date : 13.02.2015 Time Session Topic Speaker Chairperson 01.30 2.00pm
Department Of AIDS Control (DAC) Ministry of Health and Family Welfare, GOI Chandralok Building, 36 - Janpath, New Delhi
Department Of AIDS Control () Ministry of Health and Family Welfare, GOI Chandralok Building, 36 - Janpath, New Delhi - 110001 Minutes of Meeting of National TB/HIV Co-ordination Committee (NTCC) held
Secretariat: IPMRD-IPL, A/405, Sangam, S.V. Road, Opp. Surya Hospital, Abv Kotak Mahindra Bank, Santacruz (West), Mumbai Web:
Interventional Pulmonology League 2016 10th CME Organized by Date Venue Program Director Program Organizers Program Secretaries : Stepwise Approach to Interventional Pulmonology : Institute of Pulmonology,
Treatment as Prevention in India: What will it take?
Treatment as Prevention in India: What will it take? Suniti Solomon, MD FAMS Director, YRGCARE August 26, 2011 ICAAP 10, Busan, South Korea HIV IN INDIA The First Evidence The Numbers.. Source: NACO Prevalence
Agenda. KIGALI Serena Hotel, 7 th 8 th June, 2018
1 st International Steering Committee meeting 7 th 8 th June, 2018 Kigali Serena Hotel, Kigali, Rwanda Agenda KIGALI Serena Hotel, 7 th 8 th June, 2018 Objectives: Finalize the Theme and objectives of
No adolescent living with HIV left behind: a coalition for action
May 2014 No adolescent living with HIV left behind: a coalition for action Participating organisations Asia Pacific Network of People Living with HIV African Young Positives CIPHER, International AIDS
Seroprevalance of HIV, HBV, HCV and Syphilis among High Risk Group and General Population at Kims, Amalapuram, India
ISSN: 2319-7706 Volume 4 Number 12 (2015) pp. 358-362 http://www.ijcmas.com Original Research Article Seroprevalance of HIV, HBV, HCV and Syphilis among High Risk Group and General Population at Kims,
Approach To Collagen vascular Dr. G.Narsimulu Disorders with Case Scenarios. Newer Oral Anti diabetic Drugs Dr. Sanjay Reddy.
ORGANISED BY PESIMSR KUPPAM PROGRAMME SCHEDULE FOR CME (07.09.2018) 8:30am-9:45am 9:45AM 10:00AM REGISTRATION FOR THE ENTIRE CONFERENCE AND BREAKFAST Inauguration of CME Chief Guest: Dr G. Narsimulu MD,
NYS PrEP Programming. Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016
NYS PrEP Programming March 21, 2016 Lyn Stevens, NP, MS, ACRN Office of the Medical Director, AIDS Institute PrEP Monitoring in NYC and NYS February 19, 2016 March 21, 2016 2 New York State Priorities
Government of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
Vatsalyam. National Conference on Mother and Child Health Care through Ayurveda
Datta Meghe Institute of Medical Sciences (Deemed to be University) NAAC Accredited A + National Conference on Mother and Child Health Care through Ayurveda Current Avenues and Future Prospects for Mainstreaming
Page 1. Outline. Outline. Building specialized knowledge: HIV. Biological interactions. Social aspects of the epidemic. Programmatic actions
Harvard-Brazil Collaborative Public Health Field Course January 2014 Lecture # 8 Building specialized knowledge: HIV Aluisio Segurado Department of Infectious Diseases School of Medicine, University of
HIV Prevention, Care and Treatment Services in Prisons of North-Eastern States of India
HIV Prevention, Care and Treatment Services in Prisons of North-Eastern States of India About the Project The prevalence of HIV, and other blood borne viruses in prison populations is many times higher
Type 1 diabetes. Diabetes in Children-A poor cousin of type 2 diabetes. Incidence. Diabetes Nepal Conference
Type 1 diabetes Diabetes in Children-A poor cousin of type 2 diabetes Prasanna Kumar K M Dr.kmpk@gmail.com 15 FEB 2014 Kathmandu- Type 1 diabetes accounts for only about 5 10% of all cases of diabetes.
Scientific Programme 72 ND National Conference on Tuberculosis & Chest Diseases (NATCON 2017) DAY 1: AM to 5.10 PM
Scientific Programme 72 ND National Conference on Tuberculosis & Chest Diseases (NATCON 2017) DAY 1: 16.12.2017 9.00 to 5.10 THEME OF THE CONFERENCE: JOIN HANDS TO END TB TIME HALL A HALL B Hall C/Meetings
live DEC 2014 YENEPOYA UNIVERSITY, MANGALORE, INDIA. Join Radio ENT group on Facebook MediCon + IN ASSOCIATION WITH
live 12-13 DEC 2014 YENEPOYA UNIVERSITY, MANGALORE, INDIA. www.radioent.in ELIGIBLE FOR CME CREDIT POINTS BROUGHT TO YOU BY UNDER THE AEGIS OF IN ASSOCIATION WITH MediCon + www.avyayamedicon.com + Join
IAS Conference Vienna 18 th to 23 rd July 2010 overview. Paul Clift King s College Hospital/UK-CAB
IAS Conference Vienna 18 th to 23 rd July 2010 overview Paul Clift King s College Hospital/UK-CAB Overall Conference I c. 25,000 participants Covers everything HIV-related Several Pre-conferences: Faith,
Access to Healthcare for Women and Children. A Philips CSR Initiative. Sumathi/ Anoop 8/31/17 An overview
Access to Healthcare for Women and Children A Philips CSR Initiative Sumathi/ Anoop 8/31/17 An overview A BRIEF ABOUT THE COMPANY PHILIPS INDIA LTD About Philips Philips India Limited is a subsidiary of
Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs
Module 2: Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Module Time Learning Objectives To provide the participants with the basic concepts of
Sex Work in Sub-Saharan Africa : Opportunities and Challenges
Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or
1997 to 2009 M.Sc Epidemiology Student project
1997 to 20 M.Sc Epidemiology Student project S. No. Year Name of the student Title of Project 1 2001 02 Dr. Padma Raman, B.D.S Vitamin A level in recurrent respiratory infected children 2 2001 02 Dr. V.C
Academic & Public Awareness Activities. Report February 2014 to February Nagpur Chapter
Nagpur Chapter Dr. Ujjwala Deshmukh Chapter Secretary Nagpur 1 st November 2014 Public forum was organized at Indora Nagpur on cancer awareness. Dr. Alka Kumar Spoke on Cervical Cancer &Wellness. Dr. Krishna
Guidance on Performance Evaluation of In-vitro Diagnostic Medical Devices
Dated:- 07-Aug-2018 Guidance on Performance Evaluation of In-vitro Diagnostic Medical Devices As per the proviso of Clause (h), Paragraph (ii), part II of Fourth Schedule of Medical Devices Rules 2017,
HIV in Zambia MINISTRY OF HEALTH. Dr Albert Mwango, BScHB, MBChB, MPH National Antiretroviral Program Coordinator,
HIV in Zambia Dr Albert Mwango, BScHB, MBChB, MPH National Antiretroviral Program Coordinator, MINISTRY OF HEALTH 8th INTEREST WORKSHOP Intercontinental Hotel, Lusaka May 5 th -9 th, 2013 Background Clinical
transmission (MTCT) of
Training Course in Sexual and Reproductive Health Research 2013 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care Dual elimination of mother-to-child transmission (MTCT)
Population, Gender and Health in India
Population, Gender and Health in India Methods, Processes and Policies Editors K.S. James Arvind Pandey Dhananjay W Bansod Lekha Subaiya ACADEMIC FOUNDATION NEW DELHI www.academicfoundation.com Contents
was found in Chennai in 1986, India has had an AIDS epidemic. 1 In many respects, however, its extent and complexities have only recently begun
The NEW ENGLA ND JOURNAL of MEDICINE Perspective march 15, 2007 Robert Steinbrook, M.D. Since the human immunodeficiency virus (HIV) was found in Chennai in 1986, India has had an AIDS epidemic. 1 In many
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections
Common structure Universal Health Coverage SDGs Cascade of services Vision, Goals and Targets Costed Actions WHO Global Health Sector Strategies 2016-2021 HIV; Viral Hepatitis; Sexually Transmitted Infections
New Infections (all age groups)
C H A P T E R 27 Epidemiology BB Rewari The terms /AIDS were unknown just about three and half decades ago, yet it has emerged as one of the leading cause of death among young adults. In July 1981, the
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Tue, 17 Jul 2018 00:15:15 GMT) CTRI Number CTRI/2010/091/001049 [Registered on: 28/06/2010] - Last Modified On 01/02/2013 Post Graduate Thesis Type of Trial
Scholars Research Library. Changing trends of HIV infection in children with relation to the ongoing PPTCT programme
Journal of Microbiology and Biotechnology Research Scholars Research Library (http://scholarsresearchlibrary.com/archive.html) ISSN : 2231 3168 CODEN (USA) : JMBRB4 Changing trends of HIV infection in
Medical Challenges of HIV/AIDS pandemic: The WHO perspective. SOLTHIS HIV Forum
Medical Challenges of HIV/AIDS pandemic: The WHO perspective SOLTHIS HIV Forum Marco Vitoria HIV/AIDS Department World Health Organization September 2013 Topic 2002 2003 2006 2010 2013 When to start 1
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention
Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness
INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes January, 2018
Agenda: Friday, 19th January 2018 07:30-17:00. INDIAN SOCIETY FOR CLINICAL RESEARCH 11th Annual ISCR Conference Collaborative Clinical Research for better Patient outcomes 19-20 January, 2018 Hotel J.
Translating Science to end HIV in Latin America and the Caribbean
Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP
INDIAN ORTHOPEDIC RHEUMATOLOGY ASSOCIATION SCIENFIC PROGRAMME. IORACON2017 Day th August 2017 Saturday 8.30am 9.
INDIAN ORTHOPEDIC RHEUMATOLOGY ASSOCIATION SCIENFIC PROGRAMME IORACON2017 Day - 1 12 th August 2017 Saturday 8.30am 9.00am Registration 9.00 to 11.00Am SESSION-01 ORTHOPEDIC RHEUMATOLOGY Time Chairperson
Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts)
Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts) Roselyne TOBY,MD, ID specialist Infectious Disease Unit/Yaounde Central Hospital
HIV/SRHR Integration for People Living with HIV
Issue Brief 1 HIV/SRHR Integration for People Living with HIV How integration responds to the SRHR needs of People Living with HIV People living with HIV (PLHIV) have the same sexual and reproductive rights
IMPACT AND OUTCOME INDICATORS IN THE NATIONAL HIV MONITORING AND EVALUATION FRAMEWORK
IMPACT AND OUTCOME S IN THE NATIONAL HIV MONITORING AND EVALUATION FRAMEWORK 2008-2012 1. HIV Prevention IMPACT S 1. Percentage of young women and men aged 15 24 who are HIV infected (UNGASS (22), MKUKUTA)
Facts & Figures. HIV Estimates
Facts & Figures HIV Estimates - 2003 Globally, the HIV sentinel surveillance system has been recognised as an optimal mechanism to monitor trends of HIV infection in specific high-risk groups as well as
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive
Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive DR. Nicholas Muraguri OGW, MD,MPH, MBA, PhD (c) Director, Global Plan Secretariat www.zero-hiv.org
Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS
Republic of Botswana Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS Page 1 June 2012 1.0 Background HIV and AIDS remains one of the critical human development challenges in Botswana.
To provide you with the basic concepts of HIV prevention using HIV rapid tests combined with counselling.
Module 2 Integration of HIV Rapid Testing in HIV Prevention and Treatment Programs Purpose Pre-requisite Modules Learning Objectives To provide you with the basic concepts of HIV prevention using HIV rapid
BLK Super Speciality Hospital
BLK Super Speciality Hospital Department of Neonatal, Paediatric and Adolescent Medicine In association with IAP Delhi State & IMA, Karol Bagh Branch Organises PAEDIATRIC UPDATE at Hotel Jaypee Siddarth
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
Using anti-hiv drugs for prevention
Using anti-hiv drugs for prevention Highlights from AIDS 2012 (and 2 nd International Workshops on Treatment as Prevention) Tim Rogers, trogers@catie.ca Using anti-hiv Drugs for Prevention Outline Treatment
Dr. A. C. Dhariwal, Director, NCDC Directorate General of Health Services, 22, Sham Nath Marg, New Delhi
Ms. Preeti Sudan, Secretary (H&FW) Room No. 156-A Nirman Bhawan, Maulana Azad Road, New Delhi 110108 Email:secyhfw@nic.in Dr. A. C. Dhariwal, Director, NCDC Directorate General of Health Services, 22,
Positive Living among women infected with HIV.
International Journal of Scientific and Research Publications, Volume 6, Issue 12, December 2016 320 Positive Living among women infected with HIV. * Prof.N.Meenakumari B.Sc(N)M.Sc(N) ** Dr.C.Susila RN.RM,
REPORT. Organized by. Sponsored by
REPORT Organized by C.G. Bhakta Institute of Biotechnology & Maliba Pharmacy College Uka Tarsadia University Bardoli, Dist. Surat- 394350, Gujarat, India www.utu.ac.in ; www.ethnopharmacology.in Organizing
Date: November 28, 2010 Edition: Bangalore. The Times of India
Date: November 28, 2010 Edition: Bangalore The Times of India Date: November 28, 2010 Edition: Bangalore The New Indian Express Date: November 28, 2010 Edition: Bangalore DNA Date: November 29, 2010 Edition:
DOWNLOAD OR READ : NATIONAL HIV AIDS STRATEGY PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : NATIONAL HIV AIDS STRATEGY PDF EBOOK EPUB MOBI Page 1 Page 2 national hiv aids strategy national hiv aids strategy pdf national hiv aids strategy EXECUTIVE SUMMARY 1 EXECUTIVE SUMMARY
POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV
POST-EXPOSURE PROPHYLAXIS, PRE-EXPOSURE PROPHYLAXIS, & TREATMENT OF HIV DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none
HIV Treatment Evolution. Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare
HIV Treatment Evolution Kimberly Y. Smith MD MPH Vice President and Head, Global Research and Medical Strategy Viiv Healthcare Overview of the Evolution of Antiretroviral Therapy Early Treatment 1987
WHO WHO AIDS 2018 JOIN US AT
WHO AIDS 2018 JOIN US AT WHO at AIDS 2018 TEDROS GHEBREYESUS Director-General, WHO ZSUZSANNA JAKAB WHO Regional Director for Europe REN MINGHUI WHO Assistant Director-General for Communicable Diseases
Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
Progress toward Universal ART Access: Innovations and Treatment 2.0. Marco Vitoria World Health Organization September 2013
Progress toward Universal ART Access: Innovations and Treatment 2.0 Marco Vitoria World Health Organization September 2013 The need for scalable, more efficient treatment models Simpler drugs Point of
Emma Zurowski PaSH Programme Lead BHA for Equality. Peter Bampton Sexual Health Lead LGBT Foundation. gmpash.org.uk.
Emma Zurowski PaSH Programme Lead BHA for Equality Peter Bampton Sexual Health Lead LGBT Foundation gmpash.org.uk 1 to 1 Interventions Group Work Interventions Testing Outreach Website Counselling for
STI and HIV Prevention and Care among Sex Workers
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph
HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region
HIV Drug Resistance Surveillance and Monitoring in the Southeast Asia Region Padmini Srikantiah, MD MPH HIV/AIDS Unit WHO- Regional Office for Southeast Asia The HIV epidemic in Southeast Asia Estimated
South African Guidelines for the Safe Use of. Dr. Oscar Radebe
South African Guidelines for the Safe Use of PrEP in MSM Dr. Oscar Radebe Background Globally MSM(men who have sex with men) have been disproportionately at high risk of HIV transmission. Biological &
Predictors of ART adherence among HIV infected individuals in Dakar, Senegal
Journal of Medicine and Medical Science Vol. 3(4) pp. 212-216, April 2012 Available online http://www.interesjournals.org/jmms Copyright 2012 International Research Journals Full Length Research Paper
In collaboration with GLOBAL HEALTH SCIENCES, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. Training workshop
WHO COLLABORATING CENTRE FOR HIV STRATEGIC INFORMATION ANDRIJA ŠTAMPAR SCHOOL OF PUBLIC HEALTH, SCHOOL OF MEDICINE UNIVERSITY OF ZAGREB John D. Rockefeller Street No. 4, 10 000 Zagreb, Croatia Phone: +
Analysis of Transfusion Transmitted Infections Among Blood Donors:To Prepare a Road Map for its Prevention and Control
DOI: 10.7860/NJLM/2018/35142:2285 Pathology Section Original Article Analysis of Transfusion Transmitted Infections Among Blood Donors:To Prepare a Road Map for its Prevention and Control Davendra Swarup,
SOCIETY FOR ETHNOPHARMACOLOGY 23/3 Saktigarh, Kolkata , India;
; email: sfeindian@gmail.com SOCIETY FOR ETHNOPHARAMCOLOGY, INDIA ANNUAL AWARDS 2017 To recognize the outstanding contribution in the area of Ethnopharmacology and medicinal plant research, the Society
Place of addiction-informed comprehensive treatment in HIV care
Place of addiction-informed comprehensive treatment in HIV care Cecile Denis, PhD Center for Studies of Addiction, University of Pennsylvania, Philadelphia, USA University of Bordeaux, Bordeaux, France
Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new
Advancing Treatment 2.0: Progress on the 2013 Consolidated Guidelines What s new H I V / A I D S D e p a r t m e n t WHO HQ Meg Doherty, MD, MPH, PhD Coordinator Treatment and Care November 5, 2012 1 Overview
Overview of 2013 WHO consolidated ARV guidelines and update plans. Marco Vitoria HIV/AIDS Department WHO Geneva September 2014
AMDS ANNUAL STAKEHOLDERS AND PARTNERS MEETING Overview of 2013 WHO consolidated ARV guidelines and update plans Marco Vitoria HIV/AIDS Department WHO Geneva September 2014 AMDS ANNUAL STAKEHOLDERS AND
Prof D Prabhakaran, Vice President-Research PHFI
Prof D Prabhakaran, Vice President-Research PHFI Prof. Prabhakaran graduated from Bangalore Medical College, received his MD (Medicine), DM (Cardiology) degrees from All India Institute of Medical Sciences